GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medtronic, Inc. (MDT) [hlAlert]

Rating:
Buy MDT
up 36.57 %

Medtronic, Inc. (MDT) rated Buy by Banc of America Sec

Posted on: Wednesday,  Sep 10, 2008  8:25 AM ET by Banc of America Sec

Banc of America Sec rated Buy Medtronic, Inc. (NYSE: MDT) on 09/10/2008, when the stock price was $53.83.
Since then, Medtronic, Inc. has gained 36.58% as of 08/27/2015's recent price of $73.52.
If you would have followed this Banc of America Sec's recommendation on MDT, you would have gained 36.57% of your investment in 2542 days.

Medtronic, Inc. (Medtronic) is a global player in medical technology. The Company operates in seven segments that manufacture and sell device-based medical therapies: Cardiac Rhythm Disease Management, Spinal, CardioVascular, Neuromodulation, Diabetes, Surgical Technologies and Physio-Control. Through these seven segments, the Company develops, manufactures and markets its medical devices in more than 120 countries. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, diabetes, and ear, nose and throat conditions. The primary markets for products are the United States, Western Europe and Japan. In July 2008, it acquired Restore Medical, Inc. In November 2008, Medtronic acquired CryoCath Technologies Inc. In February 2009, it acquired Ablation Frontiers, Inc. and Ventor Technologies Ltd. In April 2009, Medtronic acquired CoreValve, Inc.

Integrity, objectivity and originality are cornerstones of the value–added research that we offer to corporate and institutional clients. As thought leaders, our goal is to help clients understand and adapt to changing economic conditions and events that drive markets, currencies, industries and companies worldwide. And we deliver innovative ideas based on rigorous primary research, sound principles and clear vision. Our research teams are organized by areas of expertise, from equities, fixed income and emerging markets to foreign exchange and global financial risk advisory – featuring many of the industry’s most respected analysts and economists. Through our private, password–protected Web portal, our clients have access to a comprehensive array of timely research and commentary, including: * U.S. and global economic updates and indicators * Federal budget and fiscal policy * Industry outlooks * Stock coverage and picks * Financial market strategies * Corporate bond issuer risk analysis
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/10/2008 8:25 AM Buy
None
53.83
as of 12/24/2008
1 Week down  -8.42 %
1 Month up  0.57 %
3 Months down  -8.50 %
1 YTD down  -45.04 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy